AJANTA PHARMA
|
AJANTA PHARMA Last 5 Year Balance Sheet History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| EQUITY AND LIABILITIES | |||||
| Share Capital | ₹25 Cr | ₹25 Cr | ₹25 Cr | ₹25 Cr | ₹17 Cr |
| Equity - Authorised | ₹30 Cr | ₹30 Cr | ₹30 Cr | ₹30 Cr | ₹30 Cr |
| Equity - Issued | ₹25 Cr | ₹25 Cr | ₹25 Cr | ₹25 Cr | ₹17 Cr |
| Equity Paid Up | ₹25 Cr | ₹25 Cr | ₹25 Cr | ₹25 Cr | ₹17 Cr |
| Equity Shares Forfeited | ₹0.09 Cr | ₹0.09 Cr | ₹0.09 Cr | ₹0.09 Cr | ₹0.09 Cr |
| Adjustments to Equity | - | - | - | - | - |
| Preference Capital Paid Up | - | - | - | - | - |
| Face Value | ₹2.00 | ₹2.00 | ₹2.00 | ₹2.00 | ₹2.00 |
| Share Warrants & Outstandings | ₹3.22 Cr | ₹5.18 Cr | ₹5.65 Cr | ₹0.34 Cr | ₹0.30 Cr |
| Total Reserves | ₹4,499 Cr | ₹3,760 Cr | ₹3,536 Cr | ₹3,362 Cr | ₹3,247 Cr |
| Securities Premium | ₹7.16 Cr | ₹3.66 Cr | ₹0.18 Cr | - | - |
| Capital Reserves | - | - | - | - | - |
| Profit & Loss Account Balance | ₹4,378 Cr | ₹3,672 Cr | ₹3,314 Cr | ₹3,141 Cr | ₹2,718 Cr |
| General Reserves | ₹72 Cr | ₹72 Cr | ₹211 Cr | ₹211 Cr | ₹532 Cr |
| Other Reserves | ₹42 Cr | ₹13 Cr | ₹11 Cr | ₹10 Cr | ₹-2.60 Cr |
| Reserve excluding Revaluation Reserve | ₹4,499 Cr | ₹3,760 Cr | ₹3,536 Cr | ₹3,362 Cr | ₹3,247 Cr |
| Revaluation reserve | - | - | - | - | - |
| Shareholder's Funds | ₹4,527 Cr | ₹3,790 Cr | ₹3,567 Cr | ₹3,388 Cr | ₹3,264 Cr |
| Minority Interest | - | - | - | - | - |
| Long-Term Borrowings | - | - | - | - | - |
| Secured Loans | - | - | - | ₹1.25 Cr | ₹1.64 Cr |
| Non Convertible Debentures | - | - | - | - | - |
| Converible Debentures & Bonds | - | - | - | - | - |
| Packing Credit - Bank | - | - | - | - | - |
| Inter Corporate & Security Deposit | - | - | - | - | - |
| Term Loans - Banks | - | - | - | - | - |
| Term Loans - Institutions | - | - | - | - | - |
| Other Secured | - | - | - | ₹1.25 Cr | ₹1.64 Cr |
| Unsecured Loans | - | - | - | - | - |
| Fixed Deposits - Public | - | - | - | - | - |
| Loans and advances from subsidiaries | - | - | - | - | - |
| Inter Corporate Deposits (Unsecured) | - | - | - | - | - |
| Foreign Currency Convertible Notes | - | - | - | - | - |
| Long Term Loan in Foreign Currency | - | - | - | - | - |
| Loans - Banks | - | - | - | - | - |
| Loans - Govt. | - | - | - | - | - |
| Loans - Others | - | - | - | - | - |
| Other Unsecured Loan | - | - | - | - | - |
| Deferred Tax Assets / Liabilities | ₹-71 Cr | ₹-76 Cr | ₹-26 Cr | ₹0.95 Cr | ₹46 Cr |
| Deferred Tax Assets | ₹229 Cr | ₹224 Cr | ₹169 Cr | ₹131 Cr | ₹84 Cr |
| Deferred Tax Liability | ₹158 Cr | ₹148 Cr | ₹144 Cr | ₹132 Cr | ₹130 Cr |
| Other Long Term Liabilities | ₹43 Cr | ₹38 Cr | ₹27 Cr | ₹29 Cr | ₹21 Cr |
| Long Term Trade Payables | - | - | - | - | - |
| Long Term Provisions | ₹60 Cr | ₹80 Cr | ₹40 Cr | ₹147 Cr | ₹216 Cr |
| Total Non-Current Liabilities | ₹33 Cr | ₹42 Cr | ₹41 Cr | ₹177 Cr | ₹285 Cr |
| Current Liabilities | - | - | - | - | - |
| Trade Payables | ₹544 Cr | ₹454 Cr | ₹463 Cr | ₹423 Cr | ₹327 Cr |
| Sundry Creditors | ₹544 Cr | ₹454 Cr | ₹463 Cr | ₹423 Cr | ₹327 Cr |
| Acceptances | - | - | - | - | - |
| Due to Subsidiaries- Trade Payables | - | - | - | - | - |
| Other Current Liabilities | ₹629 Cr | ₹478 Cr | ₹370 Cr | ₹669 Cr | ₹301 Cr |
| Bank Overdraft / Short term credit | ₹5.74 Cr | ₹3.50 Cr | ₹1.56 Cr | ₹3.84 Cr | ₹9.49 Cr |
| Advances received from customers | ₹102 Cr | ₹74 Cr | ₹39 Cr | ₹10 Cr | ₹52 Cr |
| Interest Accrued But Not Due | - | - | - | - | - |
| Share Application Money | - | - | - | - | - |
| Current maturity of Debentures & Bonds | - | - | - | - | - |
| Current maturity - Others | ₹5.10 Cr | ₹2.59 Cr | - | - | - |
| Other Liabilities | ₹516 Cr | ₹398 Cr | ₹329 Cr | ₹656 Cr | ₹240 Cr |
| Short Term Borrowings | ₹207 Cr | - | - | - | - |
| Secured ST Loans repayable on Demands | ₹207 Cr | - | - | - | - |
| Working Capital Loans- Sec | ₹207 Cr | - | - | - | - |
| Buyers Credits - Unsec | - | - | - | - | - |
| Commercial Borrowings- Unsec | - | - | - | - | - |
| Other Unsecured Loans | ₹-207 Cr | - | - | - | - |
| Short Term Provisions | ₹307 Cr | ₹353 Cr | ₹63 Cr | ₹47 Cr | ₹19 Cr |
| Proposed Equity Dividend | - | - | - | - | - |
| Provision for Corporate Dividend Tax | - | - | - | - | - |
| Provision for Tax | ₹277 Cr | ₹329 Cr | ₹45 Cr | ₹33 Cr | ₹7.94 Cr |
| Provision for post retirement benefits | - | - | - | - | - |
| Preference Dividend | - | - | - | - | - |
| Other Provisions | ₹30 Cr | ₹23 Cr | ₹18 Cr | ₹14 Cr | ₹11 Cr |
| Total Current Liabilities | ₹1,687 Cr | ₹1,285 Cr | ₹895 Cr | ₹1,139 Cr | ₹647 Cr |
| Total Liabilities | ₹6,247 Cr | ₹5,117 Cr | ₹4,504 Cr | ₹4,705 Cr | ₹4,197 Cr |
| ASSETS | |||||
| Gross Block | ₹3,046 Cr | ₹2,801 Cr | ₹2,389 Cr | ₹2,283 Cr | ₹2,207 Cr |
| Less: Accumulated Depreciation | ₹1,179 Cr | ₹1,039 Cr | ₹910 Cr | ₹786 Cr | ₹703 Cr |
| Less: Impairment of Assets | - | - | - | - | - |
| Net Block | ₹1,867 Cr | ₹1,762 Cr | ₹1,479 Cr | ₹1,496 Cr | ₹1,504 Cr |
| Lease Adjustment A/c | - | - | - | - | - |
| Capital Work in Progress | ₹258 Cr | ₹176 Cr | ₹256 Cr | ₹209 Cr | ₹153 Cr |
| Non Current Investments | ₹29 Cr | ₹25 Cr | ₹19 Cr | ₹25 Cr | ₹25 Cr |
| Long Term Investment | ₹29 Cr | ₹25 Cr | ₹19 Cr | ₹25 Cr | ₹25 Cr |
| Quoted | - | - | - | - | - |
| Unquoted | ₹29 Cr | ₹25 Cr | ₹19 Cr | ₹25 Cr | ₹25 Cr |
| Long Term Loans & Advances | ₹85 Cr | ₹18 Cr | ₹14 Cr | ₹135 Cr | ₹236 Cr |
| Other Non Current Assets | ₹1.57 Cr | ₹3.71 Cr | ₹4.37 Cr | ₹4.85 Cr | ₹5.88 Cr |
| Total Non-Current Assets | ₹2,240 Cr | ₹1,985 Cr | ₹1,773 Cr | ₹1,871 Cr | ₹1,932 Cr |
| Current Assets Loans & Advances | - | - | - | - | - |
| Currents Investments | ₹560 Cr | ₹439 Cr | ₹330 Cr | ₹510 Cr | ₹122 Cr |
| Quoted | ₹334 Cr | ₹429 Cr | ₹299 Cr | ₹386 Cr | ₹122 Cr |
| Unquoted | ₹226 Cr | ₹10 Cr | ₹31 Cr | ₹124 Cr | - |
| Inventories | ₹939 Cr | ₹904 Cr | ₹828 Cr | ₹816 Cr | ₹791 Cr |
| Raw Materials | ₹315 Cr | ₹281 Cr | ₹233 Cr | ₹264 Cr | ₹240 Cr |
| Work-in Progress | ₹65 Cr | ₹46 Cr | ₹54 Cr | ₹52 Cr | ₹47 Cr |
| Finished Goods | ₹223 Cr | ₹192 Cr | ₹171 Cr | ₹189 Cr | ₹180 Cr |
| Packing Materials | ₹64 Cr | ₹50 Cr | ₹55 Cr | ₹52 Cr | ₹49 Cr |
| Stores  and Spare | - | - | - | - | - |
| Other Inventory | ₹272 Cr | ₹335 Cr | ₹315 Cr | ₹258 Cr | ₹275 Cr |
| Sundry Debtors | ₹1,854 Cr | ₹1,183 Cr | ₹1,247 Cr | ₹1,057 Cr | ₹1,020 Cr |
| Debtors more than Six months | ₹101 Cr | ₹23 Cr | ₹31 Cr | ₹27 Cr | ₹21 Cr |
| Debtors Others | ₹1,759 Cr | ₹1,166 Cr | ₹1,225 Cr | ₹1,041 Cr | ₹1,014 Cr |
| Cash and Bank | ₹105 Cr | ₹176 Cr | ₹131 Cr | ₹331 Cr | ₹212 Cr |
| Cash in hand | ₹0.01 Cr | - | ₹0.01 Cr | ₹0.01 Cr | ₹0.03 Cr |
| Balances at Bank | ₹105 Cr | ₹176 Cr | ₹131 Cr | ₹331 Cr | ₹212 Cr |
| Other cash and bank balances | - | - | - | - | - |
| Other Current Assets | ₹53 Cr | ₹39 Cr | ₹54 Cr | ₹22 Cr | ₹35 Cr |
| Interest accrued on Investments | ₹8.52 Cr | ₹2.29 Cr | ₹6.54 Cr | ₹2.48 Cr | ₹0.58 Cr |
| Interest accrued on Debentures | - | - | - | - | - |
| Deposits with Government | - | - | - | - | - |
| Interest accrued and or due on loans | - | - | - | - | - |
| Prepaid Expenses | ₹33 Cr | ₹25 Cr | ₹26 Cr | ₹16 Cr | ₹16 Cr |
| Other current_assets | ₹12 Cr | ₹12 Cr | ₹21 Cr | ₹3.17 Cr | ₹19 Cr |
| Short Term Loans and Advances | ₹497 Cr | ₹378 Cr | ₹132 Cr | ₹89 Cr | ₹85 Cr |
| Advances recoverable in cash or in kind | ₹99 Cr | ₹60 Cr | ₹76 Cr | ₹47 Cr | ₹39 Cr |
| Advance income tax and TDS | ₹271 Cr | ₹289 Cr | - | - | - |
| Amounts due from directors | - | - | - | - | - |
| Due From Subsidiaries | - | - | - | - | - |
| Inter corporate deposits | - | - | - | - | - |
| Corporate Deposits | - | - | - | - | - |
| Other Loans & Advances | ₹127 Cr | ₹30 Cr | ₹56 Cr | ₹42 Cr | ₹47 Cr |
| Total Current Assets | ₹4,007 Cr | ₹3,119 Cr | ₹2,722 Cr | ₹2,825 Cr | ₹2,264 Cr |
| Net Current Assets (Including Current Investments) | ₹2,320 Cr | ₹1,834 Cr | ₹1,827 Cr | ₹1,686 Cr | ₹1,617 Cr |
| Miscellaneous Expenses not written off | - | - | - | - | - |
| Total Assets | ₹6,247 Cr | ₹5,117 Cr | ₹4,504 Cr | ₹4,705 Cr | ₹4,197 Cr |
| Contingent Liabilities | ₹8.12 Cr | ₹8.12 Cr | ₹4.42 Cr | ₹4.03 Cr | ₹6.76 Cr |
| Total Debt | ₹212 Cr | ₹2.59 Cr | ₹1.49 Cr | ₹1.43 Cr | ₹1.91 Cr |
| Book Value | - | 303.04 | 282.89 | 269.07 | 382.20 |
| Adjusted Book Value | 362.19 | 303.04 | 282.89 | 269.07 | 254.80 |
Compare Balance Sheet of peers of AJANTA PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AJANTA PHARMA | ₹39,692.0 Cr | 3.8% | 2.7% | 27.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹446,792.0 Cr | 1.4% | 1.2% | 13.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹178,152.0 Cr | -0.5% | -0.6% | 4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹152,915.0 Cr | 2.1% | 1.5% | 42.2% | Stock Analytics | |
| CIPLA | ₹116,354.0 Cr | 6.4% | 1.6% | -3.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹112,681.0 Cr | 6.2% | 1.6% | 0.2% | Stock Analytics | |
AJANTA PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AJANTA PHARMA | 3.8% |
2.7% |
27.9% |
| SENSEX | -0.4% |
0.8% |
-5.3% |
You may also like the below Video Courses